EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6

Taha Y Taha, Shahrzad Ezzatpour, Jennifer M Hayashi, Chengjin Ye, Francisco J Zapatero-Belinchón, Julia A Rosecrans, Gabriella R Kimmerly, Irene P Chen, Keith Walcott, Anna Kurianowicz, Danielle M Jorgens, Natalie R Chaplin und 15 weitere

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Taha Y Taha und 26 weiteren Autor:innen. Beteiligte Einrichtung: Gladstone Institutes, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Virus Replication, RNA, Viral. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH, Roddenberry Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has been driven by SARS-CoV-2 variants with enhanced transmission and immune escape. Apart from extensive evolution in the Spike protein, non-Spike mutations are accumulating across the entire viral genome and their functional impact is not well understood. To address the contribution of these mutations, we reconstructed genomes of recent Omicron variants with disabled Spike expression (replicons) to systematically compare their RNA replication capabilities independently from Spike. We also used a single reference replicon and complemented it with various Omicron variant Spike proteins to quantify viral entry capabilities in single-round infection assays. Viral entry and RNA replication were negatively correlated, suggesting that as variants evolve reduced entry functions under growing immune pressure on Spike, RNA replication increases as a compensatory mechanism. We identified multiple mutations across the viral genome that enhanced viral RNA replication. NSP6 emerged as a hotspot with a distinct L260F mutation independently arising in the BQ.1.1 and XBB.1.16 variants. Using mutant and revertant NSP6 viral clones, the L260F mutation was validated to enhance viral replication in cells and increase pathogenesis in mice. Notably, this mutation reduced host lipid droplet content by NSP6. Collectively, a systematic analysis of RNA replication of recent Omicron variants defined NSP6’s key role in viral RNA replication that provides insight into evolutionary trajectories of recent variants with possible therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Virus ReplicationRNA, ViralViral Nonstructural ProteinsAnimalsHumansMiceMutationSpike Glycoprotein, CoronavirusVirus InternalizationVero CellsChlorocebus aethiopsGenome, ViralRNA Replication

Substanzen

Spike Glycoprotein, CoronavirusRNA, ViralViral Nonstructural Proteinsspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Gladstone Institutes, San Francisco, California, United States of America.
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States of America.
  • Department of Microbiology, College of Agriculture and Life Sciences, Cornell University, Ithaca, New York, United States of America.
  • Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, New York, United States of America.
  • Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Department of Medicine, University of California, San Francisco, California, United States of America.

ORCID-Profile: Melanie Ott

Förderung

  • NIAID NIH HHS
  • NIH
  • Roddenberry Foundation
  • P. and E. Taft
  • Schmidt Futures
  • Gordon and Betty Moore Foundation
  • James B. Pendleton Charitable Trust
  • Chan Zuckerberg Biohub

Zitieren

APA

Taha, T. Y., Ezzatpour, S., Hayashi, J. M., Ye, C., Zapatero-Belinchón, F. J., Rosecrans, J. A., Kimmerly, G. R., Chen, I. P., Walcott, K., Kurianowicz, A., Jorgens, D. M., Chaplin, N. R., Choi, A., Buchholz, D. W., Sahler, J., Hilt, Z. T., Imbiakha, B., Vagi-Szmola, C., Montano, M., …, & Ott, M. (2025). Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013020

Vancouver

Taha TY, Ezzatpour S, Hayashi JM, Ye C, Zapatero-Belinchón FJ, Rosecrans JA, et al. Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013020

BibTeX
@article{Taha2025,
  author = {Taha, Taha Y and Ezzatpour, Shahrzad and Hayashi, Jennifer M and Ye, Chengjin and Zapatero-Belinchón, Francisco J and Rosecrans, Julia A and Kimmerly, Gabriella R and Chen, Irene P and Walcott, Keith and Kurianowicz, Anna and Jorgens, Danielle M and Chaplin, Natalie R and Choi, Annette and Buchholz, David W and Sahler, Julie and Hilt, Zachary T and Imbiakha, Brian and Vagi-Szmola, Cecilia and Montano, Mauricio and Stevenson, Erica and Gordon, Martin and Swaney, Danielle L and Krogan, Nevan J and Whittaker, Gary R and Martinez-Sobrido, Luis and Aguilar, Hector C and Ott, Melanie},
  title = {Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013020}
}
Kostenlos starten →